Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting in Patients With Obstructive Sleep Apnea (PAFOS)
Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting in Patients With Obstructive Sleep Apnea: a Multicenter Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
PE
-
Recife, PE, Brazil, 50.100-060
- Pronto Socorro Cardiológico de Pernambuco - Procape
-
-
Pernambuco
-
Recife, Pernambuco, Brazil, 50070-550
- Instituto de Medicina Integral Prof Fernando Figueira - Imip
-
-
SP
-
Sao Paulo, SP, Brazil
- INCOR - Instituto do Coração da Faculdade de Medicina da Universidade de São Paulo
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- apnea-hypopnea index > 15 events/hour
Exclusion Criteria:
- ejection fraction < 45%
- chronic atrial fibrillation
- periprocedural instability (haemodynamic, neurological)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: CPAP group
patients will receive CPAP therapy for the first 7 days after extubation from CABG
|
patients will receive CPAP therapy with Auto-CPAP
|
|
No Intervention: Control Group
Patients will receive usal care
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
atrial fibrillation
Time Frame: first 7 days after CABG
|
will be verified by holter monitoring
|
first 7 days after CABG
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Heart Diseases
- Cardiovascular Diseases
- Nervous System Diseases
- Respiratory Tract Diseases
- Respiration Disorders
- Sleep Disorders, Intrinsic
- Dyssomnias
- Sleep Wake Disorders
- Signs and Symptoms, Respiratory
- Arrhythmias, Cardiac
- Sleep Apnea Syndromes
- Sleep Apnea, Obstructive
- Apnea
- Atrial Fibrillation
Other Study ID Numbers
Other Study ID Numbers
- PAFOS01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.